One of these chemicals was eventually identified as GLP-1
Dao K et al
Key Takeaways In the Phase 3 TRIUMPH-1 trial (2026), retatrutide 12 mg produced an average 28.3% body-weight reduction at 80 weeks, with 45.3% of participants losing 30% or more ( New England Journal of Medicine / Eli Lilly, 2026 )
Importantly, ColonBroom GLP-1 Booster is not a drug, hormone, or prescription medication , and it does not contain liraglutide, semaglutide, or other pharmaceutical GLP-1 agonists
Reconstituted vial: NEVER freeze Freezing a reconstituted peptide solution causes ice crystal formation that physically disrupts the peptide's molecular structure
When the gut barrier becomes too permeable, bacterial components can leak into circulation, activating inflammatory pathways, leading to metabolic dysfunction, explains Hutchinson